Sort
23,748 grants matching “melanoma”
RAC1 Signaling Studies and Resistance to Pharmacological Inhibition of MAPK in Cancer Harboring RAC1 29S Hotspot Mutation
$343,019Suresh Kumar · National Institute On Aging · ZIA · FY2019 · AG
Mechanisms of selective therapeutic synergy of PARP-inhibition and CTLA4 blockade engaged by interferon-gamma in the ovarian tumor microenvironment
$342,987Sarah Foster Adams · University Of New Mexico Health Scis Ctr · R37 · FY2023 · CA
CpG-ODN Coated Hollow Gold Nanoshells for Photothermal Therapy
$342,894Aaron E. Foster · Bellicum Pharmaceuticals, Inc. · R01 · FY2016 · CA
CpG-ODN Coated Hollow Gold Nanoshells for Photothermal Therapy
$342,894Aaron E. Foster · Bellicum Pharmaceuticals, Inc. · R01 · FY2015 · CA
Combining senescence-inducing and senolytic agents to improve melanoma therapy
$342,876Anna E Vilgelm · Ohio State University · R37 · FY2022 · CA
Cancer Bioinformatics Services
$342,856Michael John Becich · University Of Pittsburgh At Pittsburgh · P30 · FY2015 · CA
Mechanisms of UV-Mediated Melanoma Development
$342,812Christin E Burd · Ohio State University · R01 · FY2022 · CA
The role of the tumor biofilm in determining tissue tropism
$342,795Kandice Tanner · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
PHOTODYNAMIC THERAPY (PDT) AND TUMOR IMMUNITY
$342,763Sandra O Gollnick · Roswell Park Cancer Institute Corp · R01 · FY2012 · CA
Development
$342,693Ramanuj Dasgupta · New York University School Of Medicine · P30 · FY2012 · CA
CANCER RESEARCH TRAINING PROGRAM
$342,647University Of Pennsylvania · T32 · FY2003 · CA
Rational Design of HMW-MAA Peptide Mimics
$342,612Soldano Ferrone · Roswell Park Cancer Institute Corp · R01 · FY2006 · CA
Core B: Biospecimen Repository and Processing Core
$342,571Begonya Comin-Anduix · University Of California Los Angeles · P01 · FY2023 · CA
Core B: Biospecimen Repository and Processing Core
$342,571Begonya Comin-Anduix · University Of California Los Angeles · P01 · FY2022 · CA
The Role of T Cell Avidity in Determining Tumor Immunity and Autoimmunity
$342,564Arthur Hurwitz · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Heparan sulfate proteoglycans as critical regulators of brain cancer malignancy
$342,526Joanna Phillips · University Of California, San Francisco · R01 · FY2012 · NS
Immunotherapy for Skin Cancer Precursors to Prevent Skin Cancer
$342,498Shadmehr Demehri · Massachusetts General Hospital · R01 · FY2021 · AR
Rational Design of HMW-MAA Peptide Mimics
$342,483Roswell Park Cancer Institute Corp · R01 · FY2004 · CA
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
$342,415Niroshana Anandasabapathy · Weill Medical Coll Of Cornell Univ · R01 · FY2017 · AR
Mechanistic study on synergistic photo-immunological effects of laser immunotherapy for metastatic cancers
$342,355Wei R. Chen · University Of Oklahoma · R01 · FY2020 · CA
Heparan sulfate proteoglycans as critical regulators of brain cancer malignancy
$342,347Joanna Phillips · University Of California, San Francisco · R01 · FY2014 · NS
Developmental Funds
$342,312John L. Cleveland · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2021 · CA
Developmental Funds
$342,308John L. Cleveland · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2020 · CA
Mechanisms of UV-Mediated Melanoma Development
$342,295Christin E Burd · Ohio State University · R01 · FY2023 · CA
Site Specific Drug Delivery with Light-responsive Conjugates for Photo-biomodulation
$342,275Youngjae You · State University Of New York At Buffalo · R01 · FY2023 · GM